Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Net Income (2018 - 2025)

Historic Net Income for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to $24.3 million.

  • TransMedics' Net Income rose 47711.1% to $24.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $91.8 million, marking a year-over-year increase of 18436.68%. This contributed to the annual value of $35.5 million for FY2024, which is 23964.95% up from last year.
  • As of Q3 2025, TransMedics' Net Income stood at $24.3 million, which was up 47711.1% from $34.9 million recorded in Q2 2025.
  • Over the past 5 years, TransMedics' Net Income peaked at $34.9 million during Q2 2025, and registered a low of -$25.4 million during Q3 2023.
  • Moreover, its 5-year median value for Net Income was -$2.6 million (2023), whereas its average is $744263.2.
  • In the last 5 years, TransMedics' Net Income crashed by 24233.77% in 2023 and then soared by 131818.18% in 2024.
  • TransMedics' Net Income (Quarter) stood at -$12.8 million in 2021, then soared by 45.58% to -$7.0 million in 2022, then surged by 152.56% to $3.7 million in 2023, then skyrocketed by 87.58% to $6.9 million in 2024, then skyrocketed by 254.01% to $24.3 million in 2025.
  • Its Net Income was $24.3 million in Q3 2025, compared to $34.9 million in Q2 2025 and $25.7 million in Q1 2025.